Timber Pharmaceuticals Inc (NYSE American:TMBR)

0.096
Delayed Data
As of 3:58pm ET
 -0.024 / -20.00%
Today’s Change
0.09
Today|||52-Week Range
0.92
-74.74%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$15.7M

Company Description

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus is on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and other sclerotic skin diseases. The company was founded in 2019 and is headquartered in Basking Ridge, NJ.

Contact Information

Timber Pharmaceuticals, Inc.
110 Allen Road
Basking Ridge New Jersey 07920
P:(908) 636-7160
Investor Relations:

Employees

Shareholders

Individual stakeholders7.65%
Mutual fund holders3.90%
Other institutional-2.47%

Top Executives

John KoconisChairman, President & Chief Executive Officer
Joe LuccheseCFO, Secretary, Treasurer & Executive VP
Jessica Bruno-RaizVP-Clinical Operations & Program Management
Alan MendelsohnChief Medical Officer & Executive Vice President